Kwee Yong
Impact in
- Hematology top 0.05%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Oncology top 0.5%
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
Papers in
- Hematology 231
- Multiple Myeloma Research and Treatments 200
- Hematopoietic Stem Cell Transplantation 31
- Oncology 106
- Peptidase Inhibition and Analysis 35
- Cancer Treatment and Pharmacology 27
- CAR-T cell therapy research 14
- Co-authors
- Niels W.C.J. van de Donk (3 shared papers)Charlotte Pawlyn (3 shared papers)David C. Linch (21 shared papers)Anthony H. Goldstone (15 shared papers)Shirley D’Sa (31 shared papers)Stephen Mackinnon (14 shared papers)Neil K. Rabin (66 shared papers)Asim Ijaz Khwaja (16 shared papers)
- Journals
- British Journal of Haematology (72 papers)Blood (49 papers)Transplantation and Cellular Therapy (9 papers)The Lancet Oncology (8 papers)Haematologica (8 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Kwee Yong
298 papers receiving 11.7k citations
Kwee Yong's Hit Papers
Peers
Comparison fields: 5 of 133
- Hematology 6.9k
- Oncology 4.3k
- Genetics 1.2k
- Immunology 2.2k
- Molecular Biology 4.2k
Countries citing papers authored by Kwee Yong
This map shows the geographic impact of Kwee Yong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kwee Yong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kwee Yong more than expected).
Fields of papers citing papers by Kwee Yong
This network shows the impact of papers produced by Kwee Yong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kwee Yong. The network helps show where Kwee Yong may publish in the future.
Co-authors
The 25 scholars most cited alongside Kwee Yong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 315 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial Hit paper breakdown → | 2014 | 696 |
| 2 | Multiple myeloma Hit paper breakdown → | 2021 | 627 |
| 3 | Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma Hit paper breakdown → | 2023 | 544 |
| 4 | Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study Hit paper breakdown → | 2019 | 516 |
| 5 | 2002 | 324 | |
| 6 | 2002 | 309 | |
| 7 | Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial Hit paper breakdown → | 2021 | 288 |
| 8 | 2016 | 278 | |
| 9 | 2011 | 247 | |
| 10 | 2018 | 218 | |
| 11 | 2002 | 210 | |
| 12 | 2021 | 208 | |
| 13 | 2010 | 191 | |
| 14 | 1998 | 175 | |
| 15 | 2003 | 171 | |
| 16 | 2016 | 150 | |
| 17 | 2020 | 150 | |
| 18 | 2017 | 148 | |
| 19 | 2020 | 148 | |
| 20 | Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network Hit paper breakdown → | 2023 | 140 |
About Kwee Yong
Kwee Yong is a scholar working on Hematology, Oncology, Genetics, Immunology and Molecular Biology, having authored 315 papers that have together received 12.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (200 papers), Protein Degradation and Inhibitors (64 papers), Peptidase Inhibition and Analysis (35 papers), Hematopoietic Stem Cell Transplantation (31 papers), Cancer Treatment and Pharmacology (27 papers), Chronic Lymphocytic Leukemia Research (20 papers), Ubiquitin and proteasome pathways (16 papers) and CAR-T cell therapy research (14 papers). The work is most often cited by research in Hematology (6.9k citations), Oncology (4.3k citations), Genetics (1.2k citations), Immunology (2.2k citations) and Molecular Biology (4.2k citations). Kwee Yong has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Niels W.C.J. van de Donk, Charlotte Pawlyn, David C. Linch, Anthony H. Goldstone, Shirley D’Sa, Stephen Mackinnon, Neil K. Rabin, Asim Ijaz Khwaja, Karl S. Peggs and Dean A. Smith. Their work appears in journals such as British Journal of Haematology, Blood, Transplantation and Cellular Therapy, The Lancet Oncology and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.